SGP — SpyGlass Pharma

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions ...

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Industry

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Sector

Healthcare

Exchange

NASD

First trade date

2026-02-06

The interactive platform loads with JavaScript. Research tools are for informational purposes.